HST Global (OTCMKTS:HSTC) announced its quarterly earnings results on Monday, November 20th. The company reported $0.00 earnings per share (EPS) for the quarter, Bloomberg Earnings reports.
Shares of HST Global (OTCMKTS:HSTC) remained flat at $$0.01 during midday trading on Thursday.
About HST Global
HST Global, Inc is a development-stage company. The Company is a health and wellness biotechnology company engaged in developing and/or acquiring a network of wellness centers across the world that are primarily focused on the homeopathic and alternative treatment of late stage cancer. The Company focuses on acquiring products for the treatment of individual health challenges.
Receive News & Ratings for HST Global Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HST Global Inc. and related companies with MarketBeat.com's FREE daily email newsletter.